Moderna
MRNA
#1167
Rank
โ‚ฌ15.22 B
Marketcap
39,57ย โ‚ฌ
Share price
-0.47%
Change (1 day)
-49.81%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2024 (TTM): โ‚ฌ4.56 Billion

According to Moderna 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ4.80 Billion. In 2023 the company made a revenue of โ‚ฌ6.10 Billion a decrease over the revenue in the year 2022 that were of โ‚ฌ17.59 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Moderna from 2018 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ4.56 B-25.26%
2023 โ‚ฌ6.10 B-65.28%
2022 โ‚ฌ17.59 B12.36%
2021 โ‚ฌ15.66 B6920.58%
2020 โ‚ฌ0.22 B420.22%
2019 โ‚ฌ42.88 M-60.04%
2018 โ‚ฌ0.10 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ60.04 B 1,149.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.07 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.99 B-58.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ47.46 B 887.74%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ3.37 M-99.93%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.35 B 1,634.49%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.18 B-96.19%๐Ÿ‡บ๐Ÿ‡ธ USA